All Stories

  1. Mouse PAW: reverse-translating the FINGER multimodal lifestyle intervention enhances synaptic plasticity and cognition in adult wild type female mice
  2. Gel-Assisted Proteome Position Integral Shift Assay Returns Molecular Weight to Shotgun Proteomics and Identifies Caspase 3 Substrates
  3. Silk-Ovarioids: Establishment and characterization of human ovarian primary cells 3D-model system
  4. Network analysis reveals age‐ and virus‐specific circuits in nasal epithelial cells of extremely premature infants
  5. A multi-platform analysis of human gingival crevicular fluid reveals ferroptosis as a relevant regulated cell death mechanism during the clinical progression of periodontitis
  6. TISSUE-SPECIFIC METABOLOMIC REPROGRAMMING DETERMINES THE DISEASE PATHOPHYSIOLOGY OF SARS-COV-2 VARIANTS IN HAMSTER MODEL
  7. Gel-Assisted Proteome Position Integral Shift (GAPPIS) Assay Returns Molecular Weight to Shotgun Proteomics and Identifies Novel Caspase 3 Substrates
  8. 3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation
  9. Toward Single Bacterium Proteomics
  10. Multifaceted proteome analysis at solubility, redox, and expression dimensions for target identification
  11. Analysis of local extracellular matrix identifies different aetiologies behind bicuspid and tricuspid aortic valve degeneration and suggests therapies
  12. Proteomic profile of human gingival crevicular fluid reveals specific biological and molecular processes during clinical progression of periodontitis
  13. Non-typeable Haemophilus influenzae major outer membrane protein P5 contributes to bacterial membrane stability, and affects the membrane protein composition crucial for interactions with the human host
  14. Distribution, cellular localization, and colocalization of several peptide neurotransmitters in the central nervous system ofAplysia
  15. Naturally occurring dipeptide from elite controllers with dual anti-HIV-1 mechanism
  16. NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions
  17. Genomic adaptation underlies nutrient-driven reprogramming in the malaria-causing parasite
  18. Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism
  19. Panomics reveals patient individuality as the major driver of colorectal cancer progression
  20. Impaired Immuno-Metabolic Homeostasis and Microenvironmental Influence on Neuropsychiatric Risk in Treated HIV Infection
  21. Brain endothelial cells exposure to malaria parasites links Type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption and cell metabolic adaptation
  22. Plasma proteomic profiling in postural orthostatic tachycardia syndrome (POTS) reveals new disease pathways
  23. Panomics reveals patient-individuality as the major driver for colorectal cancer progression
  24. Mapping the GALNT1 substrate landscape with versatile proteomics tools
  25. Single-Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
  26. Mass Spectrometry, Structural Analysis, and Anti-Inflammatory Properties of Photo-Cross-Linked Human Albumin Hydrogels
  27. Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids
  28. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
  29. Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
  30. Epigenetic modulators link mitochondrial redox homeostasis to cardiac function
  31. Author response: Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
  32. Nucleoside-Modified mRNA Vaccines Protect IFNAR –/– Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
  33. Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
  34. Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
  35. Mass Spectrometry-Based Analytical Strategy for Single-Cell Proteomics
  36. Ultralight ultrafast enzymes
  37. Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
  38. Single Cell Proteomics Using Multiplexed Isobaric Labeling for Mass Spectrometric Analysis
  39. Citrullination Alters the Antibacterial and Anti-Inflammatory Functions of the Host Defense Peptide Canine Cathelicidin K9CATH In Vitro
  40. Trans Cohorts Metabolomic Modulation Following Long-Term Successful Therapy in HIV-Infection
  41. Coordinated pyruvate kinase activity is crucial for metabolic adaptation and cell survival during mitochondrial dysfunction
  42. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
  43. Longitudinal blood cell transcriptomic profiling and in vitro temporal proteomics provides novel insights into metabolic reprogramming and host-immune responses against Crimean-Congo Hemorrhagic Fever Virus
  44. Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
  45. Single Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
  46. Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
  47. EPHA2 Interacts with DNA-PKcs in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells
  48. System-wide identification and prioritization of enzyme substrates by thermal analysis
  49. The one-carbon pool controls mitochondrial energy metabolism via complex I and iron-sulfur clusters
  50. Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
  51. Single Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
  52. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo Hemorrhagic Fever Viruses for novel therapeutic target
  53. Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
  54. Mutant Proteomics of Lung Adenocarcinomas Harboring Different EGFR Mutations
  55. Correction: S100A6 is a critical regulator of hematopoietic stem cells
  56. S100A6 is a critical regulator of hematopoietic stem cells
  57. Dysregulation in mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
  58. Studies on citrullinated LL-37: detection in human airways, antibacterial effects and biophysical properties
  59. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
  60. ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
  61. Current status of clinical proteogenomics in lung cancer
  62. Malondialdehyde Conjugated With Albumin Induces Pro-Inflammatory Activation of T Cells Isolated From Human Atherosclerotic Plaques Both Directly and Via Dendritic Cell–Mediated Mechanism
  63. System-wide identification and prioritization of enzyme substrates by thermal analysis (SIESTA)
  64. ProTargetMiner: A proteome signature library of anticancer molecules for functional discovery
  65. Deuteration of human carbonic anhydrase for neutron crystallography: Cell culture media, protein thermostability, and crystallization behavior
  66. Large Scale Identification of Variant Proteins in Glioma Stem Cells
  67. In vivo Distribution of Tiotropium in a Rodent Model Utilizing AP-SMALDI Mass Spectrometry Imaging
  68. Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors
  69. Relationship between HMF intake and SMF formation in vivo: An animal and human study
  70. Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging
  71. Novel insights in drug metabolism by MS imaging
  72. Mutant Proteogenomics
  73. Proteogenomics
  74. Drug localizations in tissue by mass spectrometry imaging
  75. In Vitro Transcription/Translation System: A Versatile Tool in the Search for Missing Proteins
  76. Drug compound characterization by mass spectrometry imaging in cancer tissue
  77. Quest for Missing Proteins: Update 2015 on Chromosome-Centric Human Proteome Project
  78. Erratum to: Association of chromosome 19 to lung cancer genotypes and phenotypes
  79. Association of chromosome 19 to lung cancer genotypes and phenotypes
  80. Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study
  81. Localization of sunitinib in in vivo animal and in vitro experimental models by MALDI mass spectrometry imaging
  82. Use of ENCODE Resources to Characterize Novel Proteoforms and Missing Proteins in the Human Proteome
  83. Systematic Identification of Single Amino Acid Variants in Glioma Stem-Cell-Derived Chromosome 19 Proteins
  84. SC-23 * THE ROLE OF SINGLE AMINO ACID POLYMORPHISMS IN GLIOMA STEM CELL PHENOTYPES
  85. A new look at drugs targeting malignant melanoma-An application for mass spectrometry imaging
  86. Aptamer/ISET-MS: A New Affinity-Based MALDI Technique for Improved Detection of Biomarkers
  87. Inflammatory markers in Huntington's disease plasma—A robust nanoLC–MRM-MS assay development
  88. Queries of MALDI-imaging global datasets identifying ion mass signatures associated with tissue compartments
  89. Identification of Missing Proteins: Toward the Completion of Human Proteome
  90. Integrated Chromosome 19 Transcriptomic and Proteomic Data Sets Derived from Glioma Cancer Stem-Cell Lines
  91. Developments in biobanking workflow standardization providing sample integrity and stability
  92. Experimental Models to Study Drug Distributions in Tissue Using MALDI Mass Spectrometry Imaging
  93. Accessing microenvironment compartments in formalin-fixed paraffin-embedded tissues by protein expression analysis
  94. Quantification of Human Kallikrein-2 in Clinical Samples by Selected Reaction Monitoring
  95. Identification of a Novel Proteoform of Prostate Specific Antigen (SNP-L132I) in Clinical Samples by Multiple Reaction Monitoring
  96. Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction
  97. Blood Plasma Reference Material: A Global Resource for Proteomic Research
  98. Correlation Queries for Mass Spectrometry Imaging
  99. Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
  100. International biobanking for lung cancer and COPD as the future resource for clinical protein research
  101. Standardization developments for large scale biobanks in smoking related diseases - a model system for blood sample processing and storage
  102. A Critical Evaluation of Inflammatory Markers in Huntington's Disease Plasma
  103. Clinical and Biomedical Mass Spectrometry: New Frontiers in Drug Developments and Diagnosis
  104. Chromosome 19 Annotations with Disease Speciation: A First Report from the Global Research Consortium
  105. Large scale biobanking of blood — The importance of high density sample processing procedures
  106. Standardization and Utilization of Biobank Resources in Clinical Protein Science with Examples of Emerging Applications
  107. Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry
  108. Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care
  109. Clinical Proteomics
  110. Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine
  111. Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples
  112. MRM assay for quantitation of complement components in human blood plasma — a feasibility study on multiple sclerosis
  113. State-of-the-art MS technology applications in lung disease
  114. Direct Demonstration of Tissue Uptake of an Inhaled Drug: Proof-of-Principle Study Using Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging
  115. Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging
  116. Biobank resources for future patient care: developments, principles and concepts
  117. Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
  118. Clinical Protein Science and Bioanalytical Mass Spectrometry with an Emphasis on Lung Cancer
  119. Essential tactics of tissue preparation and matrix nano-spotting for successful compound imaging mass spectrometry
  120. Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms
  121. Isotope labeled internal standards (ILIS) as a basis for quality control in clinical studies using plasma samples
  122. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
  123. Determination of dissociation constants between polyelectrolytes and proteins by affinity capillary electrophoresis
  124. Identification of novel candidate protein biomarkers for the post-polio syndrome — Implications for diagnosis, neurodegeneration and neuroinflammation
  125. General Approach for Certain Quantitative Calculations for Instance of the Variance of Reversible Adsorption to the Capillary Wall in CE
  126. Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology
  127. Activity of the Small Modified Amino Acid α-Hydroxy Glycineamide on In Vitro and In Vivo Human Immunodeficiency Virus Type 1 Capsid Assembly and Infectivity
  128. Implementation of a protein profiling platform developed as an academic‐pharmaceutical industry collaborative effort
  129. Universal method for synthesis of artificial gel antibodies by the imprinting approach combined with a unique electrophoresis technique for detection of minute structural differences of proteins, viruses and cells (bacteria). Ib. Gel antibodies against...
  130. Universal method for synthesis of artificial gel antibodies by the imprinting approach combined with a unique electrophoresis technique for detection of minute structural differences of proteins, viruses, and cells (bacteria). III: Gel antibodies again...
  131. Theoretical and nomenclatural considerations of capillary electrochromatography with monolithic stationary phases
  132. Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis
  133. Homogeneous gels for capillary electrochromatography
  134. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis
  135. Chapter 10 Technologies interfacing capillary electrophoresis to mass spectrometry
  136. Chapter 3 Peptide and protein separations by capillary electrophoresis and electrochromatography
  137. 2 Evolution and development of isoelectric focusing
  138. Hybrid microdevice electrophoresis of peptides, proteins, DNA, viruses, and bacteria in various separation media, using UV-detection
  139. High-Resolution Capillary Zone and Gel Electrophoresis of Structurally Similar Amphipathic Glutathione Conjugates Based on Interaction with -Cyclodextrins
  140. Tripeptide Interference with Human Immunodeficiency Virus Type 1 Morphogenesis
  141. A hybrid microdevice for electrophoresis and electrochromatography using UV detection
  142. Stable homogeneous gel for molecular-sieving of DNA fragments in capillary electrophoresis
  143. Enantioseparation of hydroxy acids on easy-to-prepare continuous beds for capillary electrochromatography
  144. Chiral separation of amino acids by ligand-exchange capillary electrochromatography using continuous beds
  145. A new easy-to-prepare homogeneous continuous electrochromatographic bed for enantiomer recognition
  146. A new easy-to-prepare homogeneous continuous electrochromatographic bed for enantiomer recognition
  147. Chiral separation of amino acids by ligand-exchange capillary electrochromatography using continuous beds
  148. (Normal-phase) capillary chromatography using acrylic polymer-based continuous beds
  149. Chiral separation of α-amino acids by ligand-exchange capillary electrophoresis usingN-(2-hydroxy-octyl)-L-4-hydroxyproline as a selector
  150. New set-up for capillary isoelectric focusing in uncoated capillaries